Diabetic macular edema
Conditions
Interventions
Group 1:3+PRN (pro re nata)
Group 2:6+PRN(pro re nata)
Sponsors
Inner Mongolia Chaoju Eye Hospital
Eligibility
Sex/Gender
All
Age
30 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. The patients who know about the study and sign the informed consent and are willing to perform according to the requirements of the clinical trial scheme; 2. The patients who meet the diagnostic criteria of type 2 diabetes issued by who are between 30 and 80 years old; 3. Patients who meet the criteria of non proliferative phase and diabetic macular edema recommended by American ophthalmic society and international ophthalmic society in 2003; 4. In patients with macular edema by OCT, the thickness of macular central area with a diameter of 1 m m was >= 300 µ M; 5. The best corrected visual acuity letter score of ETDRS is 78-24 (20 / 32-20 / 320); 6. Without macular grid photocoagulation, intravitreal injection of triamcinolone acetonide and intravitreal injection of anti VEGF drugs.
Exclusion criteria
Exclusion criteria: 1. The patients whose refractive stroma is turbid, which affects the observation of fundus; 2. Patients with glaucoma, retinal vein occlusion, uveitis, optic nerve disease and other fundus diseases; 3. The general condition is not good, the patients with severe cardiovascular, cerebrovascular, liver and hematopoietic diseases, diabetic nephropathy with renal failure, and the patients with serious life-threatening primary diseases and psychosis; 4. Pregnant or lactating women; 5. Patients who are participating in clinical trials of other drugs; 6. Patients who are unable to cooperate with each examination due to age, disease and other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| BCVA;CMT;Blood flow density; | — |
Countries
China
Contacts
Public ContactZhang Guisen
Inner Mongolia Chaoju Eye Hospital
Outcome results
None listed